Evolent Health, Inc. (EVH)
NYSE · Services-Management Services · Services · CIK 1628908 · fiscal year ends in Dec
Closing price $4.26 on 29 Oct 2026; 52-week range $2.17 to $7.08.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $2.1B
- Revenue growth
- -4.5%
- Net income, last twelve months
- -$505.0M
- Earnings per share
- -$4.57
- Gross margin
- 17.2%
- Operating margin
- -20.4%
- Net margin
- -24.1%
- Return on equity
- -131.8%
- Market value
- $481.6M
- Cash
- $115.7M
- Debt
- $966.5M
- Debt to equity
- 2.52
- Shares outstanding
- 113.1M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $1.9B | -$410.1M | -$534.5M | -$5.07 | – | 10-K filed 25 Feb 2026 |
| FY2024 | 31 Dec 2024 | $2.6B | -$40.5M | -$61.6M | -$0.81 | – | 10-K filed 21 Feb 2025 |
| FY2023 | 31 Dec 2023 | $2.0B | -$71.2M | -$113.0M | -$1.28 | – | 10-K filed 23 Feb 2024 |
| FY2022 | 31 Dec 2022 | $1.4B | $3.6M | -$19.2M | -$0.20 | – | 10-K filed 24 Feb 2023 |
| FY2021 | 31 Dec 2021 | $908.0M | -$42.4M | -$37.6M | -$0.44 | – | 10-K filed 24 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $652.5M | -$28.4M | -$0.25 |
| Q1 FY2026 | 31 Mar 2026 | $496.2M | -$26.6M | -$0.24 |
| Q4 FY2025 | 31 Dec 2025 | $468.7M | -$429.1M | -$3.84 |
| Q3 FY2025 | 30 Sep 2025 | $479.5M | -$20.9M | -$0.24 |
| Q2 FY2025 | 30 Jun 2025 | $444.3M | -$19.9M | -$0.44 |
| Q1 FY2025 | 31 Mar 2025 | $483.6M | -$64.6M | -$0.63 |
| Q4 FY2024 | 31 Dec 2024 | $646.5M | -$22.8M | -$0.27 |
| Q3 FY2024 | 30 Sep 2024 | $621.4M | -$23.1M | -$0.27 |
Company events
The newest 8-K filings of 162 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 6 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 4 Jun 2026 | 8-K | Shareholder vote | 5.07 |
| 7 May 2026 | 8-K | Results | 2.02, 9.01 |
| 24 Feb 2026 | 8-K | Results | 2.02, 9.01 |
| 8 Dec 2025 | 8-K | Other events | 8.01 |
| 2 Dec 2025 | 8-K | Leadership change, Investor update | 5.02, 7.01 |
| 6 Nov 2025 | 8-K | Results, Leadership change | 2.02, 5.02, 9.01 |
| 23 Sep 2025 | 8-K | Investor update, Other events | 7.01, 8.01, 9.01 |
| 21 Aug 2025 | 8-K | Material agreement, New debt, Share sale | 1.01, 2.03, 3.02, 9.01 |
| 19 Aug 2025 | 8-K | Other events | 8.01, 9.01 |
| 18 Aug 2025 | 8-K | Other events | 8.01, 9.01 |
| 7 Aug 2025 | 8-K | Results | 2.02, 9.01 |
Every filing
The newest filings with the SEC of 306 held.
| Filed | Form | Period |
|---|---|---|
| 6 Aug 2026 | 10-Q | 30 Jun 2026 |
| 6 Aug 2026 | 8-K | 6 Aug 2026 |
| 10 Jun 2026 | S-8 | – |
| 4 Jun 2026 | 8-K | 4 Jun 2026 |
| 7 May 2026 | 10-Q | 31 Mar 2026 |
| 7 May 2026 | 8-K | 7 May 2026 |
| 24 Apr 2026 | ARS | 31 Dec 2025 |
| 24 Apr 2026 | DEFA14A | – |
| 24 Apr 2026 | DEF 14A | 4 Jun 2026 |
| 25 Feb 2026 | 10-K | 31 Dec 2025 |
| 24 Feb 2026 | 8-K | 24 Feb 2026 |
| 2 Jan 2026 | S-8 | – |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 26 Aug 2026 | Mccarthy Daniel Joseph, PRESIDENT | Sale under a trading plan | 65,892 | $5.00 | $329.5K | 655,133 | 28 Aug 2026 |
| 18 Nov 2025 | Springstubb Brendan B, Director | Purchase | 10,000 | $3.82 | $38.2K | 58,821 | 19 Nov 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 26 Aug 2026 | Daniel McCarthy, Officer | 65,892 | $327.5K | 26 Aug 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 8 Sep 2026 | Morgan Stanley | 13G amended | 2.7% | 3.0M |
| 17 Jul 2026 | BlackRock Portfolio Management LLC | 13G | 5.5% | 6.2M |
| 26 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 13 Feb 2026 | Eventide Asset Management, LLC | 13G amended | 0% | 1.7K |
| 11 Feb 2026 | Morgan Stanley | 13G amended | 8.1% | 9.1M |
| 5 Feb 2026 | FMR LLC | 13G amended | 0.7% | 750.9K |
| 30 Jan 2026 | The Vanguard Group | 13G amended | 7.98% | 8.9M |
| 14 Nov 2025 | Durable Capital Partners LP | 13G amended | 0% | 0 |
| 14 Nov 2025 | Eventide Asset Management, LLC | 13G amended | 5.4% | 6.3M |
| 14 Nov 2025 | Rubicon Fund II LP | 13G | 5.21% | 5.8M |
Trades by members of the House
From each member's periodic transaction report.
| Traded | Member | Type | Amount | Disclosed |
|---|---|---|---|---|
| 11 May 2020 | Greg Gianforte (MT00) | Sale | $50,001 - $100,000 | 29 May 2020 |
| 11 Oct 2019 | Greg Gianforte (MT00) | Purchase | $100,001 - $250,000 | 27 Nov 2019 |
| 10 Sep 2019 | Greg Gianforte (MT00) | Sale | $50,001 - $100,000 | 20 Oct 2019 |
| 20 Dec 2018 | Greg Gianforte (MT00) | Purchase | $15,001 - $50,000 | 23 Jan 2019 |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 11.9M | -7.79% | 5.62 |
| 30 Sep 2026 | 12.9M | -8.26% | 5.47 |
| 15 Sep 2026 | 14.1M | -9.06% | 5.81 |
| 31 Aug 2026 | 15.5M | -1.92% | 5.83 |
| 14 Aug 2026 | 15.8M | -0.25% | 3.95 |
| 31 Jul 2026 | 15.8M | +7.68% | 3.63 |
| 15 Jul 2026 | 14.7M | -7.24% | 6.61 |
| 30 Jun 2026 | 15.8M | +8.55% | 5.9 |
Funds that hold it
From each fund's latest Form 13F.
228 funds held it at 30 Jun 2026: 99 added and 64 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 14,814,851 | $80.3M | +3,925,979 |
| Cadian Capital Management, LP | 10,814,473 | $58.6M | 0 |
| Morgan Stanley | 8,969,012 | $48.6M | -112,067 |
| UBS Group AG | 6,245,283 | $33.8M | -1,905,078 |
| Rubicon Founders LLC | 5,816,123 | $31.5M | 0 |
| Engaged Capital LLC | 5,563,912 | $30.2M | 0 |
| D. E. Shaw & Co., Inc. | 5,107,561 | $27.7M | -326,471 |
| Vanguard Capital Management LLC | 4,787,994 | $26.0M | -79,409 |
| Marshall Wace, LLP | 3,413,245 | $18.5M | +2,628,233 |
| Nuveen, LLC | 3,132,085 | $17.0M | +2,866,943 |
Peers
Companies in the same industry.
- Gartner Inc. (IT): revenue $6.5B, market value $14.2B